Literature DB >> 15161954

Treatment options for IgA nephropathy in adults: a proposal for evidence-based strategy.

Maurice Laville, Eric Alamartine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161954     DOI: 10.1093/ndt/gfh309

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  The use of the Oxford classification of IgA nephropathy to predict renal survival.

Authors:  Eric Alamartine; Catherine Sauron; Blandine Laurent; Aurore Sury; Aline Seffert; Christophe Mariat
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

2.  Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.

Authors:  Takahito Moriyama; Kayu Nakayama; Ayami Ochi; Nobuyuki Amemiya; Yuki Tsuruta; Chiari Kojima; Mitsuyo Itabashi; Takashi Takei; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-10-26       Impact factor: 2.801

3.  A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.

Authors:  Weiguo Sui; Liping Li; Wenti Che; Zuo Guimai; Jiejing Chen; Wuxian Li; Yong Dai
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 4.  Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.

Authors:  Yu-Hao Zhou; Li-Gong Tang; Shi-Lei Guo; Zhi-Chao Jin; Mei-Jing Wu; Jia-Jie Zang; Jin-Fang Xu; Chun-Fang Wu; Ying-Yi Qin; Qing Cai; Qing-Bin Gao; Shan-Shan Zhang; Dand-Hui Yu; Jia He
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.